Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry.

@article{Przybylski2010BleedingCA,
  title={Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry.},
  author={Andrzej Przybylski and Pawel Derejko and Wojciech Kwaśniewski and Dagmara Urbańczyk-Świ{\'c} and Joanna M Zakrzewska and Witold Orszulak and Micha\ol Orczykowski and Artur Filipecki and Lukasz Szumowski and Franciszek Walczak and Maria Trusz-Gluza},
  journal={Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation},
  year={2010},
  volume={18 5},
  pages={230-5}
}
Introduction. The aim of the study was to define the prevalence of bleeding events in patients treated with dual antiplatelet therapy (DAT) in comparison with patients receiving only acetylsalicylic acid (ASA).Methods. Prospective two-centre registry of all first implantations of pacemakers, cardioverter-defibrillators and cardiac resynchronisation therapy units in patients receiving ASA (n=194) or DAT (n=53).Results. Bleeding complications were detected in 27 (16.2%) patients in the ASA group… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…